Cigna Group (NYSE:CI) Shares Sold by Stephens Inc. AR

Stephens Inc. AR lowered its holdings in Cigna Group (NYSE:CI - Free Report) by 21.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,183 shares of the health services provider's stock after selling 1,674 shares during the period. Stephens Inc. AR's holdings in Cigna Group were worth $2,034,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. Putney Financial Group LLC acquired a new stake in shares of Cigna Group in the 4th quarter valued at about $36,000. Transce3nd LLC acquired a new stake in shares of Cigna Group in the 4th quarter valued at about $38,000. Wayfinding Financial LLC acquired a new stake in shares of Cigna Group in the 1st quarter valued at about $40,000. Ameriflex Group Inc. acquired a new stake in shares of Cigna Group in the 4th quarter valued at about $44,000. Finally, Heck Capital Advisors LLC acquired a new stake in shares of Cigna Group in the 4th quarter valued at about $53,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Robert W. Baird cut their target price on shares of Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a research report on Monday, June 23rd. Mizuho raised their price target on shares of Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Royal Bank Of Canada restated an "outperform" rating and issued a $371.00 price target on shares of Cigna Group in a research report on Thursday, June 26th. Finally, Barclays restated an "overweight" rating and issued a $385.00 price target (up from $382.00) on shares of Cigna Group in a research report on Monday, June 2nd. Two investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $380.39.

Cigna Group Price Performance

Shares of CI stock traded down $7.54 during midday trading on Thursday, reaching $298.28. 1,696,422 shares of the company were exchanged, compared to its average volume of 1,739,813. Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a market cap of $79.68 billion, a P/E ratio of 16.52, a PEG ratio of 0.91 and a beta of 0.44. The company's 50 day moving average price is $315.21 and its two-hundred day moving average price is $310.90. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The company had revenue of $65.45 billion for the quarter, compared to the consensus estimate of $60.39 billion. During the same period in the previous year, the firm earned $6.47 EPS. Cigna Group's revenue was up 14.4% on a year-over-year basis. On average, sell-side analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd were paid a $1.51 dividend. The ex-dividend date was Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 2.02%. Cigna Group's dividend payout ratio is currently 33.44%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.